Transparent reporting has been a central part of our CR commitment for many years, and we continue to make progress in this area. Our Novartis in Society Report (formerly the Corporate Responsibility Report) is issued at the same time as our Annual Report to provide readers with a more integrated view of Novartis.
Our purpose is to improve and extend people’s lives. We aim to develop breakthrough therapies and deliver them to as many people as possible. Building trust with our stakeholders is critical to our ability to deliver on our purpose, as well as our long-term financial performance. We have a clear strategic path that we believe will further accelerate our journey to build trust with key stakeholders and society. Our Global Health & Corporate Responsibility (GH&CR) activities are centered around four key focus areas:
Holding ourselves to the highest ethical standards
Being part of the solution on pricing and access to medicines
Helping tackle global health challenges
Being a responsible citizen
We are committed to taking real, measurable and reportable action in these key areas, and making sure that we communicate about them clearly and transparently.